Zurit Levine - 18 Mar 2026 Form 3 Insider Report for COMPUGEN LTD (CGEN)

Signature
/s/ Zurit Levine
Issuer symbol
CGEN
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:10:44 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Levine Zurit SVP, Business Development C/O COMPUGEN LTD., 26 HAROKMIM STREET, HOLON, ISRAEL /s/ Zurit Levine 18 Mar 2026 0001972527

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGEN Ordinary Shares 29,375 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 42,000 $6.65 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 31,000 $2.85 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 42,000 $3.15 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 40,000 $3.80 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 40,000 $3.24 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 45,000 $14.40 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 50,000 $6.45 Direct F2
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 60,000 $3.24 Direct F3
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 28,000 $0.8292 Direct F4
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 60,000 $1.15 Direct F5
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 42,250 $1.69 Direct F6
holding CGEN Share Option (right to buy) 18 Mar 2026 Ordinary Shares 24,000 $1.46 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 25,821 restricted stock units ("RSUs"). 7,821 RSUs vest in 11 equal quarterly installments commencing on March 31, 2026; and 18,000 RSUs vest 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F2 Fully vested.
F3 This option vested 25% on March 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F4 This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F5 This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F6 This option vested 25% on September 30, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
F7 This option vests 25% on September 30, 2026 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.